HomeCERS • NASDAQ
add
Cerus Corp
Nakaraang pagsara
$2.00
Sakop ng araw
$2.05 - $2.15
Sakop ng taon
$1.15 - $2.96
Market cap
399.72M USD
Average na Volume
1.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 57.75M | 13.66% |
Gastos sa pagpapatakbo | 30.39M | 5.40% |
Net na kita | -2.18M | 13.37% |
Net profit margin | -3.78 | 23.79% |
Kita sa bawat share | -0.01 | 0.00% |
EBITDA | -248.00K | 77.80% |
Aktuwal na % ng binabayarang buwis | -5.76% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 82.88M | 3.02% |
Kabuuang asset | 221.86M | 10.42% |
Kabuuang sagutin | 156.89M | 8.94% |
Kabuuang equity | 64.96M | — |
Natitirang share | 192.17M | — |
Presyo para makapag-book | 6.06 | — |
Return on assets | -0.73% | — |
Return on capital | -0.99% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.18M | 13.37% |
Cash mula sa mga operasyon | 6.20M | 25.79% |
Cash mula sa pag-invest | -1.38M | 81.09% |
Cash mula sa financing | -1.03M | -238.20% |
Net change in cash | 3.79M | 305.14% |
Malayang cash flow | 4.48M | -3.10% |
Tungkol
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Itinatag
Set 1991
Headquarters
Website
Mga Empleyado
268
